Loading companies…
Loading companies…
United States · Biotech · Healthtech
Develops first-in-class small molecule therapies for neurodegenerative disease via glial cell signaling platform
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed+ | $4.8M | Dementia Discovery Fund — Role not disclosedLifespan Vision Ventures — Role not disclosedMass General Brigham Ventures — Role not disclosedOno Venture Investment — Role not disclosedUTEC — Role not disclosed |